Skip to main content

Bucks County drug-device developer inks licensing deal worth a potential $45M

Inexia obtained certain rights that will enable it to use Optinose’s exhalation delivery system when developing potential therapies for neurological diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.